Transaxillary TAVR With Solely Echocardiography Guidance

Recruiting now · Not applicable

Conditions studied: Aortic Stenosis

In brief

This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).

Key facts

Study ID

NCT07035847

Run by

Chinese Academy of Medical Sciences, Fuwai Hospital

People needed

20

Starts

2024-10-01

Expected to finish

2026-12-31

Last updated by the study team

2026-02-27

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• symptomatic severe AS determined by echocardiography and Doppler that requiring aortic valve replacement, defined as: mean gradient ≥40 mmHg, peak aortic velocity ≥4 m/s, and aortic valve area (AVA) ≤1 cm2 (or an indexed AVA ≤0.6 cm2/m2)
• suitable for Transaxillary TAVR

You may not qualify if…

• required hybrid procedures or concomitant interventions on other cardiac malformations
• inoperable due to extremely high surgical risk or severe comorbidities
• untreated clinically significant (>70% obstruction) proximal vessel coronary vascular disease amenable to revascularization
• previously undergone aortic valve replacement.

Where it is running

• Fuwai Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.